Delivery Order SPE2DB22D2009-SPE2DB25FM0KY
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,922.76 to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100 100s, a antimalarial medication commonly used for malaria prophylaxis and treatment in military personnel and Department of Defense beneficiaries. The contract, awarded on July 29, 2025, with an ultimate completion date of July 30, 2025, represents a firm fixed price procurement with no set-aside designation, indicating competitive award to this qualified...
- The Defense Logistics Agency awarded a delivery order valued at $1,100.20 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Atovaquone-Proguanil 250-100 (100 tablets). This is a firm fixed-price delivery order with no set-aside designation, demonstrating that the award was competitively procured. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of July 30, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a $22,386 firm fixed price delivery order to AmerisourceBergen Drug Corp for 100 units of Atovaquone-Proguanil 250-100, an antimalarial medication commonly used by military personnel for malaria prophylaxis. The delivery order, issued on August 1, 2025, with an ultimate completion date of August 4, 2025, represents a non-competitive award under the company's existing indefinite delivery contract with DLA. AmerisourceBergen Drug Corp, headquartered in...
- The Defense Logistics Agency awarded a delivery order valued at $5,504.61 to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100 (100 count) on August 11, 2025, with completion scheduled for August 12, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award status. Performance will be executed from the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,245.97 to AmerisourceBergen Drug Corp for the supply of Atovaquone-Proguanil 250-100 (100 tablets), a antimalarial medication used primarily for malaria prophylaxis and treatment in military personnel. The contract was awarded on August 7, 2025, with an ultimate completion date of August 8, 2025, under firm fixed price terms with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $3,469.83 to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Atovaquone-Proguanil 250-100mg in 100-count units. This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 8, 2025, performed at the contractor's facility in Conshohocken, Pennsylvania. The antimalarial medication delivery supports federal medical procurement requirements, particularly for military and veteran...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Atovaquone-Proguanil 250-100 tablets in a quantity of 100 units, with a ceiling value of $1,343.16. This contract is structured as a firm fixed-price delivery order with an ultimate completion date of July 25, 2025, and represents a non-competitive set-aside transaction. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $24,468 delivery order to AmerisourceBergen Drug Corp on December 5, 2024, for the supply of Atovaquone-Proguanil 250-100 tablets in quantities of 100, with an ultimate completion date of December 6, 2024. This contract represents a firm fixed price, competitively awarded delivery order with no set-aside designation, performed at the contractor's facility in Conshohocken, Pennsylvania. Atovaquone-Proguanil is an antimalarial medication commonly used for...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Atovaquone-Proguanil 250-100mg tablets (100 count) with a contract value of $5,372.64. The award, issued on July 24, 2025, represents a firm fixed-price delivery order with an ultimate completion date of July 25, 2025. This non-set-aside contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Atovaquone-Proguanil is an antimalarial...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,029.48 to AmerisourceBergen Drug Corp for the supply of Atovaquone-Proguanil 250-100 tablets (100-count units) with an ultimate completion date of August 4, 2025. This firm fixed-price delivery order, issued on August 1, 2025, represents a non-set-aside, competitively awarded contract utilizing AmerisourceBergen's established indefinite delivery contract with DLA Troop Support Medical (SPE2DX, valued at $999.99 billion...
- SPE2DB22D2009Indefinite Delivery Contract
- SPE2DB22D2009-SPE2DB25FM0KYDelivery Order
The Defense Logistics Agency awarded a $8,058.96 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100 100S on July 22, 2025, with an ultimate completion date of July 23, 2025. This non-set-aside contract represents a small-value pharmaceutical procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The award was fulfilled from the company's place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen operates as a major pharmaceutical distributor and critical vendor for federal medical procurement. This delivery order falls under AmerisourceBergen's comprehensive $999.999 billion IDC with DLA Troop Support Medical (designated SPE2DX, running through December 2026), which serves as a global pharmaceutical support vehicle supplying medications and medical supplies to military healthcare programs. Atovaquone-Proguanil is an antimalarial pharmaceutical commonly used for malaria prevention and treatment in military personnel deployed to endemic regions. As the prime contractor on this agreement, AmerisourceBergen continues to demonstrate its capability to fulfill federal medical supply requirements through competitive procurement processes and maintain a diversified portfolio of pharmaceutical deliveries supporting Defense Health Agency and related government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.1k | 7/22/25 |